These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with myocardial infarction. Doggen CJ, Bertina RM, Cats VM, Reitsma PH, Rosendaal FR. Thromb Haemost; 1999 Jul; 82(1):115-20. PubMed ID: 10456464 [Abstract] [Full Text] [Related]
3. Plasminogen activator inhibitor-1 5G/5G genotype is associated with early spontaneous recanalization of the infarct-related artery in patients presenting with acute ST-elevation myocardial infarction. Cagliyan CE, Yuregir OO, Balli M, Tekin K, Akilli RE, Bozdogan ST, Turkmen S, Deniz A, Baykan OA, Aslan H, Cayli M. Coron Artery Dis; 2013 May; 24(3):196-200. PubMed ID: 23283030 [Abstract] [Full Text] [Related]
4. Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion. Kuhli-Hattenbach C, Hellstern P, Nägler DK, Kohnen T, Hattenbach LO. Ophthalmic Genet; 2017 May; 38(5):413-417. PubMed ID: 28085526 [Abstract] [Full Text] [Related]
5. Reduced carriership of 4G allele of plasminogen activator inhibitor-1 4G/5G polymorphism in very young survivors of myocardial infarction. Rallidis LS, Gialeraki A, Merkouri E, Liakos G, Dagres N, Sionis D, Travlou A, Lekakis J, Kremastinos DT. J Thromb Thrombolysis; 2010 May; 29(4):497-502. PubMed ID: 19844663 [Abstract] [Full Text] [Related]
6. Lack of association of a common polymorphism of the plasminogen activator inhibitor-1 gene with coronary artery disease and myocardial infarction. Anderson JL, Muhlestein JB, Habashi J, Carlquist JF, Bair TL, Elmer SP, Davis BP. J Am Coll Cardiol; 1999 Nov 15; 34(6):1778-83. PubMed ID: 10577569 [Abstract] [Full Text] [Related]
8. Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Miletich JP. Circulation; 1997 Jan 07; 95(1):59-62. PubMed ID: 8994417 [Abstract] [Full Text] [Related]
9. Effect of plasminogen activator inhibitor-1 4G/5G polymorphism in Turkish deep vein thrombotic patients with and without FV1691 G-A. Akar N, Yilmaz E, Akar E, Avcu F, Yalçin A, Cin S. Thromb Res; 2000 Feb 15; 97(4):227-30. PubMed ID: 10674409 [Abstract] [Full Text] [Related]
13. The 4G/5G polymorphism of the plasminogen activator inhibitor gene is associated with the time course of progression to acute coronary syndromes. Iwai N, Shimoike H, Nakamura Y, Tamaki S, Kinoshita M. Atherosclerosis; 1998 Jan 15; 136(1):109-14. PubMed ID: 9544737 [Abstract] [Full Text] [Related]
19. An effect of the PAI-1 4G/5G polymorphism on cholesterol levels may explain conflicting associations with myocardial infarction and stroke. Boncoraglio GB, Bodini A, Brambilla C, Carriero MR, Ciusani E, Parati EA. Cerebrovasc Dis; 2006 Sep 15; 22(2-3):191-5. PubMed ID: 16735791 [Abstract] [Full Text] [Related]
20. Plasminogen activator inhibitor-1 promoter 4G/5G genotype and plasma levels in relation to a history of myocardial infarction in patients characterized by coronary angiography. Ossei-Gerning N, Mansfield MW, Stickland MH, Wilson IJ, Grant PJ. Arterioscler Thromb Vasc Biol; 1997 Jan 15; 17(1):33-7. PubMed ID: 9012634 [Abstract] [Full Text] [Related] Page: [Next] [New Search]